• Jump to main navigation
  • Jump to content
U of U Health
  • Billing & Insurance
  • MyChart
Search
  • Find A U of U Health Doctor
  • All U of U Health Services
  • All U of U Health Locations
  • For All U of U Health Patients & Visitors
    • Patient Services
      • Questions About Your Bill?
      • Urgent Care
      • Where to Stay
      • Patients & Family Services
      • Clinical Trials
    • University of Utah Hospital
      • University of Utah Hospital
      • Staying at the Hospital
      • Parking & Valet
      • Looking for Another Location?
    • General Questions
      • 801-581-2668
      • Find an Interpreter
      • About U of U Health
  • Billing & Insurance
  • MyChart
  • Search

Jose Nativi-Nicolau, MD

  • Clinical Information
  • Academic Information
  • Clinical Trials
  • Patient Resources
  • Videos & News
No Rating Available?
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the minimum.
38 4.7 out of 5 Patient Rating

Languages Spoken: English, Spanish

Dr. Nativi-Nicolau is an Associate Professor of Medicine at the University of Utah and is the Cardiovascular Director of the Amyloidosis Program at the University of Utah and Huntsman Cancer Institute. He also serves as Director of the Coronary Care Unit, at University of Utah Health.

Dr. Nativi-Nicolau received his medical degree from University of Panama and completed his Internal Medicine Residency at Drexel University College of Medicine in Philadelphia, Pennsylvania. He accomplished his Cardiology Fellowship at the University of Utah in Salt Lake City, then continued his training with an Advanced Heart Failure and Transplantation Fellowship at the Mayo Clinic in Rochester Minnesota. Dr. Nativi-Nicolau is board certified in Internal Medicine, Cardiovascular Disease, and Advanced Heart Failure and Transplantation and is a member of the Alpha-Omega-Alpha American Honor Medical Society. He is also a Fellow of the American College of Cardiology and the Heart Failure Society of America.

His clinical and research interests include cardiac amyloidosis, heart failure, mechanical circulatory support and heart transplantation.

Clinical Locations

Billings Clinic

315 North 25th Street
Billings, MT  59101

Huntsman Cancer Hospital
Hematology Clinic

801-587-4724

1950 Circle of Hope
Salt Lake City, UT  84112
Map

Saint Alphonsus Regional Medical Center

208-367-4278

6140 West Curtisian
Boise, ID  83706
Ste. 200

University Hospital
Heart Failure Clinic

801-587-2199

50 N Medical Dr
Salt Lake City, UT  84132
Map

University Hospital
Heart Transplant Clinic

801-585-3693

50 N Medical Dr
Salt Lake City, UT  84132
Map

Veterans Administration Medical Center

801-584-1235

500 S Foothill Blvd
Salt Lake City, UT  84149

Specialties

  • Heart Failure
  • Heart Transplant
  • Cardiac Mechanical Support
  • Amyloidosis
  • Cardiology
  • Cardioversion

Board Certification and Academic Information

Academic Departments Internal Medicine - Associate Professor (Clinical)
Academic Divisions Cardiovascular Medicine
Board Certification American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Advanced Heart Failure & Transplant Cardiology)
American Board of Internal Medicine (Sub: Cardiovascular Disease)
National Board of Medical Examiners

Patient Rating

The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Learn About Our Survey

Likelihood of recommending care provider

4.7/ 5

Care provider's explanation of condition/problem

4.7/ 5

Care provider's effort to include me in decisions

4.6/ 5

Wait time at clinic

4.3/ 5

Care provider's concern for questions & worries

4.8/ 5

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

UofU Patient November 15, 2020
UH HOSPITALS AND CLINICS

5 out of 5 stars

I have sent many patient's to Dr. Drakos and his staff, because he is up front, and does not play head games with you. He makes you understand your health issues and he is there to make you well the best he can.

UofU Patient November 10, 2020
HUNTSMAN CANCER CENTER

5 out of 5 stars

Good experience.

UofU Patient September 03, 2020
HUNTSMAN CANCER CENTER

5 out of 5 stars

Dr. Nativi and Chris spent time to cover all of my concerns and even took me to the parking lot to talk to my family

UofU Patient July 23, 2020
UH HOSPITALS AND CLINICS

5 out of 5 stars

Both the PA and the physician asked good questions and were very reassuring.

UofU Patient May 10, 2020
HUNTSMAN CANCER CENTER

4 out of 5 stars

good

UofU Patient February 28, 2020
HUNTSMAN CANCER CENTER

5 out of 5 stars

It is always a good experience with Dr. Nativi. .

UofU Patient February 02, 2020
HUNTSMAN CANCER CENTER

5 out of 5 stars

It was nice to have some time alone with Dr. Nativi. Got some questions answered and he was especially caring and helpful in explaining my situation.

UofU Patient December 13, 2019
UH HOSPITALS AND CLINICS

5 out of 5 stars

I was very impressed with Dr. Nativi . He seemed very concerned, but was very honest that WE have a long, difficult road ahead us. I had a question about a upcoming trip. He was honest and said that it would not be happening in April. I appreciated his honesty.

UofU Patient August 30, 2019
HUNTSMAN CANCER CENTER

5 out of 5 stars

couldn't be better. excellent in every way

UofU Patient April 05, 2019
HUNTSMAN CANCER CENTER

5 out of 5 stars

Thank you for all of you that care enough to know what you're doing...

UofU Patient November 09, 2018
HUNTSMAN CANCER CENTER

5 out of 5 stars

good

UofU Patient October 13, 2018
UH HOSPITALS AND CLINICS

5 out of 5 stars

Dr. Nativi is the best doctor. He listens to every concern and thinks about every possible connection that could be causing my symptoms, which I greatly appreciate since I have multiple diseases and a complex case. He's not only concerned about health, but he also takes an interest in my life and makes sure I can stay as healthy as possible to keep doing the things I enjoy.

UofU Patient August 07, 2018
HUNTSMAN CANCER CENTER

5 out of 5 stars

Excellent Physician and Head Nurse Jared Cowley!!! All the care givers that helped us were fabulous!! Great team!!!

UofU Patient June 16, 2018

We were treated as if we were the only patient of the day

UofU Patient May 13, 2018

Was pleased in all respects by Dr. Nativi, the NP and the Nurse

UofU Patient March 24, 2018

They had the technician update my medicine & supplimental regimen so my records could be current and accurate. when the main Doctors came in, I brought up some of my concerns regarding some suggestions to my overall treatment. They expounded on & explained a certain request I had concerns about, and have listened to my concerns. :D

UofU Patient December 02, 2017

_____ was helped to understand the upcoming surgical procedure and left feeling confident about it.

UofU Patient November 21, 2017

Outstanding Very professional

UofU Patient November 18, 2017

good

UofU Patient November 17, 2017

all good

UofU Patient October 29, 2017

I always and already have it recommended to them to multiple people.

UofU Patient October 22, 2017

outstanding

UofU Patient September 15, 2017

both dr Nativi and Jared are knowledgeable and friendly

UofU Patient September 12, 2017

I was astounded at the length of time that Dr. Nativi and his entire staff spent with my wife and me. He was very persistent in asking if we had any further concerns or questions. It was probably the best experience I have ever had with a consulting physician

UofU Patient August 17, 2017

dr`s nativi, kovacsovic and their staff, (not to ignore dr randall, when i saw him) have in formed and treated me w/the best care i could hope for and i am grateful to these brilliant and skilled physicians and their supporting staff....

UofU Patient August 16, 2017

I really appreciate the PA and Doctor spending time with me conversing. I didn't feel they were rushed or pushing me through.

UofU Patient June 24, 2017

Very helpful and gave instructions to help improve my quality of life, to help me solve a few problems resulting from effects of medications.

UofU Patient March 14, 2017

All of my experiences with Dr. Nativi and his staff have been positive.

UofU Patient November 21, 2016

my father was able to communicate in spanish with the provider. The provider was very professional and answered all my fathers questions.

UofU Patient November 18, 2016

My care providers ARE THE BEST!

UofU Patient November 08, 2016

tell all about what a great place this is and should go there

UofU Patient November 06, 2016

very good

UofU Patient June 14, 2016

Excellent care. Both the PA and the physician took the time to answer all of my questions and treated me like a person and not a number.

UofU Patient July 25, 2015

Both Dr. Nativi and Dr. Kovascoviks, as well as Dr. Low ((Dr K's Fellow)' were exceptional physicians. They were kind, caring, informative. Dr Low asked excellent questions that were thoughtful and intuitive. All three men imprssed me.

UofU Patient July 10, 2015

for waiting from over an hour to sometimes 4 for only a 10 minute visit seems insaine.

UofU Patient July 09, 2015

probably the best available thank you

UofU Patient July 17, 2014

I have often complimented the Heart Transplant Staff to others. I feel the U of U staff in general shows the highest degree of care and professionalism of any that I have dealt with in the health profession.

UofU Patient April 08, 2013

while I have been impressed with the care given by my main cardiologist, I have found his physician's assistant (I believe that is her title,) to be curt, condescending, and annoyed with my questions or concerns.

Dr. Nativi-Nicolau is an Associate Professor of Medicine at the University of Utah and is the Cardiovascular Director of the Amyloidosis Program at the University of Utah and Huntsman Cancer Institute. He also serves as Director of the Coronary Care Unit, at University of Utah Health.

Dr. Nativi-Nicolau received his medical degree from University of Panama and completed his Internal Medicine Residency at Drexel University College of Medicine in Philadelphia, Pennsylvania. He accomplished his Cardiology Fellowship at the University of Utah in Salt Lake City, then continued his training with an Advanced Heart Failure and Transplantation Fellowship at the Mayo Clinic in Rochester Minnesota. Dr. Nativi-Nicolau is board certified in Internal Medicine, Cardiovascular Disease, and Advanced Heart Failure and Transplantation and is a member of the Alpha-Omega-Alpha American Honor Medical Society. He is also a Fellow of the American College of Cardiology and the Heart Failure Society of America.

His clinical and research interests include cardiac amyloidosis, heart failure, mechanical circulatory support and heart transplantation.

Academic Locations

School of Medicine

801-585-2340

30 N 1900 E
Division of Cardiovascular Medicine, 4A100
Salt Lake City, UT  84132

Research Statement

My area of research interest include patient-centered outcomes in patients with mechanical circulatory support, specifically related to quality of life.

Board Certification and Academic Information

Academic Departments Internal Medicine - Associate Professor (Clinical)
Academic Divisions Cardiovascular Medicine
Board Certification American Board of Internal Medicine (Internal Medicine)
American Board of Internal Medicine (Sub: Advanced Heart Failure & Transplant Cardiology)
American Board of Internal Medicine (Sub: Cardiovascular Disease)
National Board of Medical Examiners

Education History

Graduate Training University of Utah
Clinical Investigation
M.S.
Fellowship Mayo Clinic
Advanced Heart Failure
Fellow
Fellowship University of Utah
Cardiovascular Disease
Fellow
Residency Drexel University College of Medicine
Internal Medicine
Resident
Internship Drexel University College of Medicine
Internal Medicine
Intern
Internship Dionisio Arrocha Hospital
Second Year
Transitional Internship
Internship Metropolitan Hospital
First Year
Transitional Internship
Professional Medical University of Panama
Medicine
M.D.

Selected Publications - Journal Articles

Journal Article

  1. Gertz M, Adams D, Ando Y, Beiro JM, Bokhari S, Coelho T, Comenzo RL, Damy T, Dorbala S, Drachman BM, Fontana M, Gillmore JD, Grogan M, Hawkins PN, Lousada I, Kristen AV, Ruberg FL, Suhr OB, Maurer MS, Nativi-Nicolau J, Quarta CC, Rapezzi C, Witteles R, Merlini G (2020). Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner. BMC Family Practice, 21(1), 198.
  2. Pregenzer-Wenzler A, Abraham J, Barrell K, Kovacsovics T, Nativi-Nicolau J (2020). Utility of Biomarkers in Cardiac Amyloidosis. JACC Heart Fail, 8(9), 701-711.
  3. Kittleson MM, Maurer MS, Ambardekar AV, Bullock-Palmer RP, Chang PP, Eisen HJ, Nair AP, Nativi-Nicolau J, Ruberg FL, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology (2020). Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association. Circulation, 142(1), e7-e22.
  4. Varshney AS, Berg DD, Katz JN, Baird-Zars VM, Bohula EA, Carnicelli AP, Chaudhry SP, Guo J, Lawler PR, Nativi-Nicolau J, Sinha SS, Teuteberg JJ, van Diepen S, Morrow DA, Critical Care Cardiology Trials Network Investigators (2020). Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes. JAMA Cardiol, 5(6), 703-708.
  5. Yin MY, Strege J, Gilbert EM, Stehlik J, McKellar SH, Elmer A, Anderson T, Aljuaid M, Nativi-Nicolau J, Koliopoulou AG, Davis E, Fang JC, Drakos SG, Selzman CH, Wever-Pinzon O (2019). Impact of Shared Care in Remote Areas for Patients With Left Ventricular Assist Devices. JACC Heart Fail, 8(4), 302-312.
  6. Stehlik J, Schmalfuss C, Bozkurt B, Nativi-Nicolau J, Wohlfahrt P, Wegerich S, Rose K, Ray R, Schofield R, Deswal A, Sekaric J, Anand S, Richards D, Hanson H, Pipke M, Pham M (2020). Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LINK-HF Multicenter Study. Circ Heart Fail, 13(3), e006513.
  7. Berg DD, Barnett CF, Kenigsberg BB, Papolos A, Alviar CL, Baird-Zars VM, Barsness GW, Bohula EA, Brennan J, Burke JA, Carnicelli AP, Chaudhry SP, Cremer PC, Daniels LB, DeFilippis AP, Gerber DA, Granger CB, Hollenberg S, Horowitz JM, Gladden JD, Katz JN, Keeley EC, Keller N, Kontos MC, Lawler PR, Menon V, Metkus TS, Miller PE, Nativi-Nicolau J, Newby LK, Park JG, Phreaner N, Roswell RO, Schulman SP, Sinha SS, Snell RJ, Solomon MA, Teuteberg JJ, Tymchak W, van Diepen S, Morrow DA (2019). Clinical Practice Patterns in Temporary Mechanical Circulatory Support for Shock in the Critical Care Cardiology Trials Network (CCCTN) Registry. Circ Heart Fail, 12(11), e006635.
  8. Maurer MS, Bokhari S, Damy T, Dorbala S, Drachman BM, Fontana M, Grogan M, Kristen AV, Lousada I, Nativi-Nicolau J, Cristina Quarta C, Rapezzi C, Ruberg FL, Witteles R, Merlini G (2019). Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis. Circ Heart Fail, 12(9), e006075.
  9. Yin MY, Wever-Pinzon O, Mehra MR, Selzman CH, Toll AE, Cherikh WS, Nativi-Nicolau J, Fang JC, Kfoury AG, Gilbert EM, Kemeyou L, McKellar SH, Koliopoulou A, Vaduganathan M, Drakos SG, Stehlik J (2019). Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices. J Heart Lung Transplant, 38(8), 858-869.
  10. Judge DP, Heitner SB, Falk RH, Maurer MS, Shah SJ, Witteles RM, Grogan M, Selby VN, Jacoby D, Hanna M, Nativi-Nicolau J, Patel J, Rao S, Sinha U, Turtle CW, Fox JC (2019). Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy. J Am Coll Cardiol, 74(3), 285-295.
  11. Iosif Taleb, Antigone G Koliopoulou, Anwar Tandar, Stephen H McKellar, Joseph E Tonna, Jose Nativi-Nicolau, Miguel Alvarez Villela, Frederick Welt, Josef Stehlik, Edward M Gilbert, Omar Wever-Pinzon, Jack H Morshedzadeh, Elizabeth Dranow, Craig H Selzman, James C Fang, Stavros G Drakos (2019). Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support. Circ Heart Fail, 140(1), 98-100.
  12. Nativi-Nicolau J, Stehlik J, Al-Dulaimi R, Rodriguez C, Jaramillo J, Conte J, Kovacsovics T, Cowley J, Abraham J, Barrel K, Drakos S, Ryan J, Maurer MS, Fang J (2019). Chronotropic incompetence and autonomic dysfunction as mechanisms of dyspnoea in patients with late stage cardiac amyloidosis. Amyloid, 26(sup1), 134-135.
  13. Ruiz-Negrn N, Nativi-Nicolau J, Maurer MS, Moran AE, Kovacsovics T, Bellows BK (2019). Cost-effectiveness of technetium pyrophosphate scintigraphy versus heart biopsy for the diagnosis of transthyretin amyloidosis. Amyloid, 26(sup1), 71-72.
  14. Yin MY, Ruckel S, Kfoury AG, McKellar SH, Taleb I, Gilbert EM, Nativi-Nicolau J, Stehlik J, Reid BB, Koliopoulou A, Stoddard GJ, Fang JC, Drakos SG, Selzman CH, Wever-Pinzon O (2018). Novel Model to Predict Gastrointestinal Bleeding During Left Ventricular Assist Device Support. Circ Heart Fail, 11(11), e005267.
  15. Nativi-Nicolau J, Maurer MS (2018). Amyloidosis cardiomyopathy: update in the diagnosis and treatment of the most common types. Curr Opin Cardiol, 33(5), 571-579.
  16. Daud A, Xu D, Revelo MP, Shah Z, Drakos SG, Dranow E, Stoddard G, Kfoury AG, Hammond MEH, Nativi-Nicolau J, Alharethi R, Miller DV, Gilbert EM, Wever-Pinzon O, McKellar SH, Afshar K, Khan F, Fang JC, Selzman CH, Stehlik J (2018). Microvascular Loss and Diastolic Dysfunction in Severe Symptomatic Cardiac Allograft Vasculopathy. Circ Heart Fail, 11(8), e004759.
  17. Varedi D, Kovacsovics T, Downs Kelly E, Abraham J, Cowley J, Barrell K, Revelo MP, Stehlik J, Drakos S, Marrouche N, Wilson B, Swanson EA, Fang J, Nativi-Nicolau J (2018). Unmasking Early Wild-Type Transthyretin Amyloidosis Cardiomyopathy in a Patient With Refractory Atrial Fibrillation and Unremarkable Cardiac Imaging. Circ Heart Fail, 11(7), e004812.
  18. Barrett-OKeefe Z, Lee JF, Berbert A, Witman MAH, Nativi-Nicolau J, Stehlik J, Richardson RS, Wray DW (2018). Metaboreceptor activation in heart failure with reduced ejection fraction: Linking cardiac and peripheral vascular haemodynamics. Exp Physiol, 103(6), 807-818.
  19. Bonios MJ, Koliopoulou A, Wever-Pinzon O, Taleb I, Stehlik J, Xu W, Wever-Pinzon J, Catino A, Kfoury AG, Horne BD, Nativi-Nicolau J, Adamopoulos SN, Fang JC, Selzman CH, Bax JJ, Drakos SG (2017). Cardiac Rotational Mechanics As a Predictor of Myocardial Recovery in Heart Failure Patients Undergoing Chronic Mechanical Circulatory Support: A Pilot Study. Circ Cardiovasc Imaging, 11(4), e007117.
  20. Stehlik J, Rodriguez-Correa C, Spertus JA, Biber J, Nativi-Nicolau J, Zickmund S, Steinberg BA, Peritz DC, Walker A, Hess J, Drakos SG, Kfoury AG, Fang JC, Selzman CH, Hess R (2017). Implementation of Real-Time Assessment of Patient-Reported Outcomes in a Heart Failure Clinic: A Feasibility Study. J Card Fail, 23(11), 813-816.
  21. AbouEzzeddine OF, Wong YW, Mentz RJ, Raza SS, Nativi-Nicolau J, Kociol RD, McNulty SE, Anstrom KJ, Hernandez AF, Redfield MM, NHLBI Heart Failure Clinical Research Network (2015). Evaluation of Novel Metrics of Symptom Relief in Acute Heart Failure: The Worst Symptom Score. J Card Fail, 22(11), 853-858.
  22. Grupper A, Nativi-Nicolau J, Maleszewski JJ, Geske JR, Kremers WK, Edwards BS, Kushwaha SS, Pereira NL (2016). Circulating Galectin-3 Levels Are Persistently Elevated After Heart Transplantation and Are Associated With Renal Dysfunction. JACC Heart Fail, 4(11), 847-856.
  23. Ko BS, Drakos S, Kfoury AG, Hurst D, Stoddard GJ, Willis CA, Delgado JC, Hammond EH, Gilbert EM, Alharethi R, Revelo MP, Nativi-Nicolau J, Reid BB, McKellar SH, Wever-Pinzon O, Miller DV, Eckels DD, Fang JC, Selzman CH, Stehlik J, Utah Transplant Affiliated Hospitals UTAH Cardiac Transplant Program (2016). Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant. J Heart Lung Transplant, 35(8), 1024-30.
  24. Suksaranjit P, Ryan JJ, Han FT, Nativi-Nicolau J, Revelo MP, Wilson BD (2015). Shortness of breath and cardiac conduction abnormality caused by infiltrative cardiomyopathy. Eur Heart J, 36(33), 2238.
  25. Wachter SB, McCandless SP, Gilbert EM, Stoddard GJ, Kfoury AG, Reid BB, McKellar SH, Nativi-Nicolau J, Saidi A, Barney J, McCreath L, Koliopoulou A, Wright SE, Fang JC, Stehlik J, Selzman CH, Drakos SG (2015). Elevated resting heart rate in heart transplant recipients: innocent bystander or adverse prognostic indicator? Clin Transplant, 29(9), 829-34.
  26. Barrett-OKeefe Z, Lee JF, Berbert A, Witman MA, Nativi-Nicolau J, Stehlik J, Richardson RS, Wray DW (2014). Hemodynamic responses to small muscle mass exercise in heart failure patients with reduced ejection fraction. Am J Physiol Heart Circ Physiol, 307(10), H1512-20.
  27. Nativi-Nicolau J, Selzman CH, Fang JC, Stehlik J (2014). Pharmacologic therapies for acute cardiogenic shock. Curr Opin Cardiol, 29(3), 250-7.
  28. Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Gilbert EM, Everitt M, Alharethi R, Brunisholz K, Bader FM, Li DY, Selzman CH, Stehlik J (2013). Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified? Circulation, 127(4), 452-62.
  29. Witman MA, McDaniel J, Fjeldstad AS, Ives SJ, Zhao J, Nativi JN, Stehlik J, Wray DW, Richardson RS (2012). A differing role of oxidative stress in the regulation of central and peripheral hemodynamics during exercise in heart failure. Am J Physiol Heart Circ Physiol, 303(10), H1237-44.
  30. Witman MA, Fjeldstad AS, McDaniel J, Ives SJ, Zhao J, Barrett-OKeefe Z, Nativi JN, Stehlik J, Wray DW, Richardson RS (2012). Vascular function and the role of oxidative stress in heart failure, heart transplant, and beyond. Hypertension, 60(3), 659-68.
  31. Wever Pinzon O, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik J (2011). Impact of donor left ventricular hypertrophy on survival after heart transplant. Am J Transplant, 11(12), 2755-61.
  32. Nativi JN, Drakos SG, Kucheryavaya AY, Edwards LB, Selzman CH, Taylor DO, Hertz MI, Kfoury AG, Stehlik J (2011). Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant, 30(8), 854-61.
  33. Hayman MA, Nativi JN, Stehlik J, McDaniel J, Fjeldstad AS, Ives SJ, Walter Wray D, Bader F, Gilbert EM, Richardson RS (2010). Understanding exercise-induced hyperemia: central and peripheral hemodynamic responses to passive limb movement in heart transplant recipients. Am J Physiol Heart Circ Physiol, 299(5), H1653-9.
  34. Nativi JN, Brown RN, Taylor DO, Kfoury AG, Kirklin JK, Stehlik J (2010). Temporal trends in heart transplantation from high-risk donors: are there lessons to be learned? A multi-institutional analysis. J Heart Lung Transplant, 29(8), 847-52.
  35. Nativi JN, Kfoury AG, Myrick C, Peters M, Renlund D, Gilbert EM, Bader F, Singhal AK, Everitt M, Fisher P, Bull DA, Selzman C, Stehlik J (2010). Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantation. J Heart Lung Transplant, 29(3), 235-9.

Review

  1. Nativi-Nicolau J, Ryan JJ, Fang JC (2014). Current therapeutic approach in heart failure with preserved ejection fraction. [Review]. Heart Failure Clinics, 10(3), 525-38.

Editorial

  1. Nativi-Nicolau J (2018). Serum Transthyretin: Predictor of Amyloidosis Outcomes? Circ Heart Fail, 11(2), e004802.

Letter

  1. Mondesir FL, Zickmund SL, Yang S, Perry G, Galyean P, Nativi-Nicolau J, Kemeyou L, Spertus JA, Stehlik J (2020). Patient Perspectives on the Completion and Use of Patient-Reported Outcome Surveys in Routine Clinical Care for Heart Failure. [Letter to the editor]. Circ Cardiovasc Qual Outcomes, 13(9), e007027.
  2. Daud A, Mehra MR, Siu A, Johnson MR, Perch M, Budev M, Zakharia Y, Cheng R, Nativi-Nicolau J, Stehlik J (2020). Immune checkpoint inhibitors in heart or lung transplantation: Early results from a registry initiative. [Letter to the editor]. J Heart Lung Transplant, 39(6), 604-606.
  3. Taleb I, Koliopoulou AG, Tandar A, McKellar SH, Tonna JE, Nativi-Nicolau J, Alvarez Villela M, Welt F, Stehlik J, Gilbert EM, Wever-Pinzon O, Morshedzadeh JH, Dranow E, Selzman CH, Fang JC, Drakos SG (2019). Shock Team Approach in Refractory Cardiogenic Shock Requiring Short-Term Mechanical Circulatory Support: A Proof of Concept. [Letter to the editor]. Circulation, 140(1), 98-100.

Global Impact

Education History

Internship Dionisio Arrocha Hospital
Second Year
Transitional Internship
Internship Metropolitan Hospital
First Year
Transitional Internship
Professional Medical University of Panama
Medicine
M.D.

Service

04/01/2015 Leader Standards and Guidelines Committee Workforce. Identify the need to update existing standards and guidelines and to develop new standards and guidelines relevant to the mission of the Society. Global

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of AG10 in Subjects with Symptomatic Transthyretin Amyloid Cardiomyopathy (ATTRIBUTE-CM Trial)

Description: Active, not recruiting Keywords: Amyloidosis, Heart failure Principal Investigator: Jose Nativi-Nicolau

ATTR-ACT Extension Study

Description: Recruiting Keywords: Heart Failure, Amyloidosis Principal Investigator: Jose Nativi-Nicolau

CCCTN Registry

Description: Keywords: Principal Investigator: Jose Nativi-Nicolau

Amyloid Registry Thaos Study

Description: Recruiting Keywords: Heart Failure, Amyloidosis Principal Investigator: Jose Nativi-Nicolau

News Articles

A Transplant Success in Panama

Amyloidosis Clinic Opens in Utah, Third in the Country Specializing in Treatment of the Rare Disease

The Scope & Other Podcasts

  • Dr. Jose Nativi-Nicolau HF Interview
  • Emerging therapies for Amyloidosis Cardiomyopathy
  • Coordinating Care in a Specialized Clinic a Proven Way to Treat Amyloidosis
  • What is Amyloidosis?
  • What is Amyloidosis?
  • What Causes Amyloidosis?
  • How Is Amyloidosis Diagnosed?
  • What Makes Treatment Here Different

Videos

What is Amyloidosis?

What Makes Treatment Here Different

How Is Amyloidosis Diagnosed?

Dr. Jose Nativi-Nicolau HF Interview

What Causes Amyloidosis?

Emerging therapies for Amyloidosis Cardiomyopathy

Site Links

  • About Us
  • Academics & Research
  • Billing
  • Jobs
  • Giving
  • Maps & Directions
  • Newsroom
  • The Imagine Perfect Care Program

Helpful Links

  • Referring Providers
  • Find an Interpreter
  • Patient Rights & Responsibilities
  • Disclaimer
  • Privacy Statement
  • DNV GL Public Information Policy Statement
  • Non-Discrimination Policy
  • Webmaster

Contact Us

University of Utah Health

50 North Medical Drive
Salt Lake City, UT 84132

801-581-2121

  • Facebook
  • Twitter
  • Youtube

University of Utah

All clinical services and programs are part of University of Utah Health Hospitals and Clinics.

Copyright © 2021 University of Utah Health